Differential diagnosis of facial pain and guidelines for management

British Journal of Anaesthesia

Volumn 111, Issue 1, 2013, Pages 95-104

  Zakrzewska, J M ^a  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

diagnosis; facial pain; guidelines

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; ANTICONVULSIVE AGENT; BACLOFEN; BENZODIAZEPINE; BOTULINUM TOXIN; CARBAMAZEPINE; CORTICOSTEROID; GABAPENTIN; LAMOTRIGINE; PREGABALIN; ROPIVACAINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ACUPUNCTURE; ARTHROSCOPY; ATYPICAL ODONTALGIA; BACKACHE; BURNING MOUTH SYNDROME; COGNITIVE THERAPY; COMPUTER ASSISTED TOMOGRAPHY; CRYOTHERAPY; DIFFERENTIAL DIAGNOSIS; DISEASE SEVERITY; DRUG MEGADOSE; FACE PAIN; FIBROMYALGIA; GIANT CELL ARTERITIS; GINGIVA DISEASE; GLOSSOPHARYNGEAL NEURALGIA; HEADACHE; HUMAN; JAW DISEASE; MAXILLA SINUSITIS; MIGRAINE; NEURECTOMY; NEUROPATHIC PAIN; NUCLEAR MAGNETIC RESONANCE IMAGING; PAIN ASSESSMENT; PHYSIOTHERAPY; POST STROKE PAIN; POSTHERPETIC NEURALGIA; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SALIVARY GLAND DISEASE; SHORT UNILATERAL NEURALGIFORM PAIN WITH AUTONOMIC FEATURE; TOOTH PAIN; TRIGEMINUS NEURALGIA;

EID: 84880246902     PISSN: 00070912     EISSN: 14716771     Source Type: Journal    
DOI: 10.1093/bja/aet125     Document Type: Article

References (82)

1. Merskey H, Bogduk N. Classification of Chronic Pain. Descriptors of Chronic Pain Syndromes and Definitions of Pain Terms, 2nd Edn. Seattle: IASP Press, 1994
2. Anonymous. The international classification of headache disorders: 2nd Edn. Cephalalgia 2004; 24 (Suppl. 1): 9-160
3. Durham J, Steele JG, Wassell RW, Exley C. Living with uncertainty: temporomandibular disorders. J Dent Res 2010; 89: 827-30
4. Zakrzewska JM. Orofacial Pain, 1st Edn. Oxford: Oxford University Press, 2009
5. Hegarty AM, Zakrzewska JM. Differential diagnosis for orofacial pain, including sinusitis, TMD, trigeminal neuralgia. Dent Update 2011; 38: 396-408
6. Klasser GD, Balasubramaniam R, Epstein J. Topical reviewconnective tissue diseases: orofacial manifestations including pain. J Orofac Pain 2007; 21: 171-84
7. Velly AM, Look JO, Carlson C, et al. The effect of catastrophizing and depression on chronic pain-a prospective cohort study of temporomandibular muscle and joint pain disorders. Pain 2011; 152: 2377-83
8. Wiesinger B, Malker H, Englund E, Wanman A. Back pain in relation to musculoskeletal disorders in the jaw-face: a matched case-control study. Pain 2007; 131: 311-9
9. Balasubramaniam R, de LR, Zhu H, Nickerson RB, Okeson JP, Carlson CR. Prevalence of temporomandibular disorders in fibromyalgia and failed back syndrome patients: a blinded prospective comparison study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2007; 104: 204-16
10. Velly AM, Look JO, Schiffman E, et al. The effect of fibromyalgia and widespread pain on the clinically significant temporomandibular muscle and joint pain disorders-a prospective 18-month cohort study. J Pain 2010; 11: 1155-64
11. Anderson GC, John MT, Ohrbach R, et al. Influence of headache frequency on clinical signs and symptoms of TMD in subjects with temple headache and TMD pain. Pain 2011; 152: 765-71
12. Schiffman E, Ohrbach R, List T, et al. Diagnostic criteria for headache attributed to temporomandibular disorders. Cephalalgia 2012; 32: 683-92
13. Fillingim RB, Ohrbach R, Greenspan JD, et al. Potential psychosocial risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA case-control study. J Pain 2011; 12: T46-60
14. Fillingim RB, Slade GD, Diatchenko L, et al. Summary of findings from the OPPERA baseline case-control study: implications and future directions. J Pain 2011; 12: T102-T107
15. Ohrbach R, Fillingim RB, Mulkey F, et al. Clinical findings and pain symptoms as potential risk factors for chronic TMD: descriptive data and empirically identified domains from the OPPERA casecontrol study. J Pain 2011; 12: T27-T45
16. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992; 6: 301-55
17. Hasanain F, Durham J, Moufti A, Steen IN, Wassell RW. Adapting the diagnostic definitions of the RDC/TMD to routine clinical practice: a feasibility study. J Dent 2009; 37: 955-62
18. Ohrbach R, Turner JA, Sherman JJ, et al. The research diagnostic criteria for temporomandibular disorders. IV: evaluation of psychometric properties of the Axis II measures. J Orofac Pain 2010; 24: 48-62
19. Cairns B, List T, Michelotti A, Ohrbach R, Svensson P. JOR-CORE recommendations on rehabilitation of temporomandibular disorders. J Oral Rehabil 2010; 37: 481-9
20. Petersson A. What you can and cannot see in TMJ imaging-an overview related to the RDC/TMD diagnostic system. J Oral Rehabil 2010; 37: 771-8
21. Brister H, Turner JA, Aaron LA, Mancl L. Self-efficacy is associated with pain, functioning, and coping in patients with chronic temporomandibular disorder pain. J Orofac Pain 2006; 20: 115-24
22. Fricton JR, Ouyang W, Nixdorf DR, Schiffman EL, Velly AM, Look JO. Critical appraisal of methods used in randomized controlled trials of treatments for temporomandibular disorders. J Orofac Pain 2010; 24: 139-51
23. List T, Axelsson S. Management of TMD: evidence from systematic reviews and meta-analyses. J Oral Rehabil 2010; 37: 430-51
24. Craane B, Dijkstra PU, Stappaerts K, DE LA. Methodological quality of a systematic review on physical therapy for temporomandibular disorders: influence of hand search and quality scales. Clin Oral Investig 2012; 16: 295-303
25. Ebrahim S, Montoya L, Busse JW, Carrasco-Labra A, Guyatt GH. The effectiveness of splint therapy in patients with temporomandibular disorders: a systematic review and meta-analysis. J Am Dent Assoc 2012; 143: 847-57
26. Dahlstrom L, Carlsson GE. Temporomandibular disorders and oral health-related quality of life. A systematic review. Acta Odontol Scand 2010; 68: 80-5
27. Gray R, Al-Ani Z. Risk management in clinical practice. Part 8. Temporomandibular disorders. Br Dent J 2010; 209: 433-49
28. Michelotti A, Iodice G, Vollaro S, Steenks MH, Farella M. Evaluation of the short-term effectiveness of education versus an occlusal splint for the treatment of myofascial pain of the jaw muscles. J Am Dent Assoc 2012; 143: 47-53
29. Cho SH, Whang WW. Acupuncture for temporomandibular disorders: a systematic review. J Orofac Pain 2010; 24: 152-62
30. La TR, Goddard G, De-la-Hoz JL, et al. Acupuncture in the treatment of pain in temporomandibular disorders: a systematic review and meta-analysis of randomized controlled trials. Clin J Pain 2010; 26: 541-50
31. Petrucci A, Sgolastra F, Gatto R, Mattei A, Monaco A. Effectiveness of low-level laser therapy in temporomandibular disorders: a systematic review and meta-analysis. J Orofac Pain 2011; 25: 298-307
32. Melis M, Di GM, Zawawi KH. Low level laser therapy for the treatment of temporomandibular disorders: a systematic review of the literature. Cranio 2012; 30: 304-12
33. Liu HX, Liang QJ, Xiao P, Jiao HX, Gao Y, Ahmetjiang A. The effectiveness of cognitive-behavioural therapy for temporomandibular disorders: a systematic review. J Oral Rehabil 2012; 39: 55-62
34. Michelotti A, Steenks MH, Farella M, Parisini F, Cimino R, Martina R. The additional value of a home physical therapy regimen versus patient education only for the treatment of myofascial pain of the jaw muscles: short-term results of a randomized clinical trial. J Orofac Pain 2004; 18: 114-25
35. Michelotti A, de WA, Steenks M, Farella M. Home-exercise regimes for the management of non-specific temporomandibular disorders. J Oral Rehabil 2005; 32: 779-85
36. Mujakperuo HR, Watson M, Morrison R, Macfarlane TV. Pharmacological interventions for pain in patients with temporomandibular disorders. Cochrane Database Syst Rev 2010; 10: CD004715
37. Plesh O, Curtis D, Levine J, McCall WD Jr. Amitriptyline treatment of chronic pain in patients with temporomandibular disorders. J Oral Rehabil 2000; 27: 834-41
38. Ernberg M, Hedenberg-Magnusson B, List T, Svensson P. Efficacy of botulinum toxin type A for treatment of persistent myofascial TMD pain: a randomized, controlled, double-blind multicenter study. Pain 2011; 152: 1988-96
39. Guo C, Shi Z, Revington P. Arthrocentesis and lavage for treating temporomandibular joint disorders. Cochrane Database Syst Rev 2009; 4: CD004973
40. Rigon M, Pereira LM, Bortoluzzi MC, Loguercio AD, Ramos AL, Cardoso JR. Arthroscopy for temporomandibular disorders. Cochrane Database Syst Rev 2011; 5: CD006385
41. O'connor AB, Dworkin RH. Treatment of neuropathic pain: an overview of recent guidelines. Am J Med 2009; 122: S22-S32
42. Nixdorf DR, Drangsholt MT, Ettlin DA, et al. Classifying orofacial pains: a new proposal of taxonomy based on ontology. J Oral Rehabil 2011; 39: 161-9
43. Benoliel R, Eliav E. Neuropathic orofacial pain. Oral Maxillofac Surg Clin North Am 2008; 20: 237-54, vii
44. Renton T, Yilmaz Z. Profiling of patients presenting with posttraumatic neuropathy of the trigeminal nerve. J Orofac Pain 2011; 25: 333-44
45. Benoliel R, Zadik Y, Eliav E, Sharav Y. Peripheral painful traumatic trigeminal neuropathy: clinical features in cases and proposal of novel diagnostic criteria. J Orofac Pain 2012; 26: 49-58
46. Baad-Hansen L. Atypical odontalgia-pathophysiology and clinical management. J Oral Rehabil 2008; 35: 1-11
47. Koopman JS, Huygen FJ, Dieleman JP, de MM, Sturkenboom MC. Pharmacological treatment of neuropathic facial pain in the Dutch general population. J Pain 2009; 11: 264-72
48. Forssell H, Jaaskelainen S, Tenovuo O, Hinkka S. Sensory dysfunction in burning mouth syndrome. Pain 2002; 99: 41-7
49. Albuquerque RJ, de LR, Carlson CR, Okeson JP, Miller CS, Andersen AH. Cerebral activation during thermal stimulation of patients who have burning mouth disorder: an fMRI study. Pain 2006; 122: 223-34
50. Sardella A, Lodi G, Demarosi F, Bez C, Cassano S, Carrassi A. Burning mouth syndrome: a retrospective study investigating spontaneous remission and response to treatments. Oral Dis 2006; 12: 152-5
51. Zakrzewska JM, Forssell H, Glenny AM. Interventions for the treatment of burning mouth syndrome. Cochrane Database Syst Rev 2005; 1: CD002779
52. Buchanan J, Zakrzewska J. Burning mouth syndrome. Clin Evid 2005; 14: 1685-90
53. Femiano F, Gombos F, Scully C. Burning mouth syndrome: the efficacy of lipoic acid on subgroups. J Eur Acad Dermatol Venereol 2004; 18: 676-8
54. Femiano F, Scully C. Burning mouth syndrome (BMS): double blind controlled study of alpha-lipoic acid (thioctic acid) therapy. J Oral Pathol Med 2002; 31: 267-9
55. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome-a randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009; 38: 254-61
56. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alpha-lipoic acid in burning mouth syndrome: a double-blind, randomized, placebo-controlled study. Eur J Pain 2009; 13: 492-6
57. Lopez-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med 2012; 42: 295-301
58. Lopez-D'alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of Burning Mouth Syndrome: a randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011; 16: e635-e640
59. Gremeau-Richard C, Woda A, Navez ML, et al. Topical clonazepam in stomatodynia: a randomised placebo-controlled study. Pain 2004; 108: 51-7
60. Petruzzi M, Lauritano D, De BM, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: short-term results of a pilot study. J Oral Pathol Med 2004; 33: 111-4
61. Sardella A, Uglietti D, Demarosi F, Lodi G, Bez C, Carrassi A. Benzydamine hydrochloride oral rinses in management of burning mouth syndrome. A clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999; 88: 683-6
62. Tammiala-Salonen T, Forssell H. Trazodone in burning mouth pain: a placebo-controlled, double-blind study. J Orofacial Pain 1999; 13: 83-8
63. Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: a randomized placebo-controlled study. J Oral Pathol Med 2008; 37: 395-401
64. Toida M, Kato K, Makita H, et al. Palliative effect of lafutidine on oral burning sensation. J Oral Pathol Med 2009; 38: 262-8
65. Limonadi FM, McCartney S, Burchiel KJ. Design of an artificial neural network for diagnosis of facial pain syndromes. Stereotact Funct Neurosurg 2006; 84: 212-20
66. Obermann M, Yoon MS, Ese D, et al. Impaired trigeminal nociceptive processing in patients with trigeminal neuralgia. Neurology 2007; 69: 835-41
67. Cruccu G, Gronseth G, Alksne J, et al. AAN-EFNS guidelines on trigeminal neuralgia management. Eur J Neurol 2008; 15: 1013-28
68. Gronseth G, Cruccu G, Alksne J, et al. Practice parameter: the diagnostic evaluation and treatment of trigeminal neuralgia (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology and the European Federation of Neurological Societies. Neurology 2008; 71: 1183-90
69. Wiffen PJ, Derry S, Moore RA, McQuay HJ. Carbamazepine for acute and chronic pain in adults. Cochrane Database Syst Rev 2011; 1: CD005451
70. Wiffen PJ, Derry S, Moore RA. Lamotrigine for acute and chronic pain. Cochrane Database Syst Rev 2011; 2: CD006044
71. Lemos L, Flores S, Oliveira P, Almeida A. Gabapentin supplemented with ropivacain block of trigger points improves pain control and quality of life in trigeminal neuralgia patients when compared with gabapentin alone. Clin J Pain 2008; 24: 64-75
72. Obermann M, Yoon MS, Sensen K, Maschke M, Diener HC, Katsarava Z. Efficacy of pregabalin in the treatment of trigeminal neuralgia. Cephalalgia 2008; 28: 174-81
73. Zakrzewska JM, Akram H. Neurosurgical interventions for the treatment of classical trigeminal neuralgia. Cochrane Database Syst Rev 2011; 9: CD007312
74. Zakrzewska JM, Coakham HB. Microvascular decompression for trigeminal neuralgia: update. Curr Opin Neurol 2012; 25: 296-301
75. Napenas JJ, Zakrzewska JM. Diagnosis and management of trigeminal neuropathic pains. Pain Manag 2011; 1: 353-65
76. Cohen AS, Matharu MS, Goadsby PJ. Trigeminal autonomic cephalalgias: current and future treatments. Headache 2007; 47: 969-80
77. Simms HN, Honey CR. The importance of autonomic symptoms in trigeminal neuralgia. Clinical article. J Neurosurg 2011; 115: 210-6
78. May A, Leone M, Afra J, et al. EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006; 13: 1066-77
79. Hassan N, Dasgupta B, Barraclough K. Giant cell arteritis. Br Med J 2011; 342: d3019
80. Klit H, Finnerup NB, Jensen TS. Central post-stroke pain: clinical characteristics, pathophysiology, and management. Lancet Neurol 2009; 8: 857-68
81. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome. A qualitative systematic review. J Orofac Pain 2003; 17: 301-10
82. Aggarwal VR, Lovell K, Peters S, Javidi H, Joughin A, Goldthorpe J. Psychosocial interventions for the management of chronic orofacial pain. Cochrane Database Syst Rev 2011; 11: CD008456